Alternative Medicine :: 69% older Americans using complementary and alternative medicine

In spite of the high use of complementary and alternative medicine (CAM) among people age 50 or older, 69 percent of those who use CAM do not talk to their doctors about it, according to a new survey conducted by AARP and the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health. The survey examined conversations between patients and their physicians regarding CAM use.

Neurofibromatosis :: Tracing the pathways of neurofibromatosis

New research into the mechanisms of neurofibromatosis finds that flaws in the gene Nf1 can lead to a biochemical domino effect that results in tumors. The research, which appears in the January 10 issue of the Journal of Neuroscience, seeks to identify the biochemical pathway responsible for tumors in people with the genetic disorder. Researchers built their case based on evidence from dozens of painstaking experiments on genetically engineered fruit flies.

Cancer :: Cetuximab may prolong survival for head and neck cancer patients

Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.

Genome :: Microbiologists crack genome of a parasite that causes a common STD

Scientists at UCLA and NYU have deciphered the genome of the parasite causing trichomoniasis, and their research may lead to new approaches to improve the diagnosis and treatment of this common sexually transmitted disease. Trichomoniasis affects an estimated 170 million people a year, with more than five million cases reported in North America.

Court :: Wal-Mart Statement on Maryland Federal Court’s Decision

We are pleased that the U.S. Court of Appeals has affirmed the Maryland Federal Court?s decision. Not only was this legislation widely viewed as bad public policy, the courts have confirmed that it violates the law. This politically-motivated legislation did nothing to control the cost of health care or improve access to health care, so it?s no wonder that legislators across the country have rejected this as bad public policy.

Stomach Cancer :: Scientists reverse precursor to gut cancer

Researchers say that they have developed a way of reversing cellular changes in the gut that can lead to a form of gullet cancer. The changes cause a condition known as Barrett’s oesophagus which causes the normally scaly lining of the oesophagus to be replaced by glandular lining, like the inside of the stomach.

Influenza :: HHS Funds Advanced Development of H5N1 Influenza Vaccines

HHS Secretary Mike Leavitt announced today that the department has awarded contracts totaling $132.5 million to three vaccine makers for the advanced development of H5N1 influenza vaccines using an immune system booster called an adjuvant. An adjuvant is a substance that may be added to a vaccine to increase the body?s immune response to the vaccine?s active ingredient, called antigen.

Flu :: 1918 killer flu virus tested on monkeys

In a study of nonhuman primates infected with the influenza virus that killed 50 million people in 1918, an international team of scientists has found a critical clue to how the virus killed so quickly and efficiently.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack